Mapp Bio Secures Federal Contract For Sudan Virus Therapy.

The San Diego Union-Tribune (9/29, Fikes) reported Mapp Biopharmaceutical, which has developed an antibody therapy for Ebola, has won a $14.8 million federal contract to create a similar treatment for the related Sudan virus. Mapp Bio “has options for an...